Metraipolis › archive › dc_7b1bf46d6072
SARS-CoV-2 serosurvey in Health Care Workers of the Veneto Region — Europe PMC PPR:PPR192031
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR192031
- DOI
- 10.1101/2020.07.23.20160457
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-08T00:24:22.614Z
- SHA-256 of the archived text
0666b532a3d06d39fc5b63a449a98efe560373a507f98ebc2b547d37fbe4c486- Stable URL of this page
https://metraipolis.com/documento/dc_7b1bf46d6072
How to cite
SARS-CoV-2 serosurvey in Health Care Workers of the Veneto Region — Europe PMC PPR:PPR192031 — Europe PMC, https://europepmc.org/article/PPR/PPR192031 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_7b1bf46d6072 (Metraipolis archive dc_7b1bf46d6072, sha256 0666b532a3d06d39fc5b63a449a98efe560373a507f98ebc2b547d37fbe4c486)
BibTeX
@misc{dc7b1bf46d6072,
title = {SARS-CoV-2 serosurvey in Health Care Workers of the Veneto Region — Europe PMC PPR:PPR192031},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR192031},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_7b1bf46d6072; sha256 0666b532a3d06d39fc5b63a449a98efe560373a507f98ebc2b547d37fbe4c486},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC, https://europepmc.org/article/PPR/PPR192031. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: The ongoing outbreak of coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses formidable challenges to all health care systems. Serological assays may improve disease management when appropriately used, for better understanding the antibody responses mounted upon SARS-CoV-2 infection and for assessing its real prevalence. Although testing the whole population is impratical, well-designed serosurveys in selected subpopulations in specific risk groups may provide valuable information. Aim: we evaluated the prevalence of SARS-CoV-2 infection in health care workers who underwent molecular testing with reverse transcription real-time polymerase chain reaction (rRT-PCR) in the main hospitals of the Veneto Region by measuring specific antibodies (Abs). Methods: both IgM and IgG antibodies against SARS-Cov-2 S-antigen and N-protein were measured using a validated chemiluminescent analytical system (CLIA) called Maglumi™ 2000 Plus (New Industries Biomedical EngineeringCo., Ltd [Snibe], Shenzhen, China) Results: A total of 8285 health care workers were tested. SARS-CoV-2 specific antibodies (IgM, IgG or both) were detectable in 378 cases (4.6%, 95% CI 4.1-5.0%). Seroconversion was observed in 4.4% women and 5% men, but the difference was not significant. Although detectable antibodies were found in all severe COVID-19 patients (100%), lower seropositivity was found in mild disease (83%) and the lowest prevalence (58%) was observed in asymptomatic subjects. Conclusion: Seroprevalence surveys are of utmost importance for understanding the rate of population that has already developed antibodies against SARS-CoV-2. The present study has the statistical power to define precisely the circulation of SARS-CoV-2 in a cohort of health workers in our region, with its prevalence (4.6%) reflecting a relatively low circulation. Symptomatic individuals or those hospitalized for medical care were 100% antibody positive, whilst Abs were only detectable in 58% of asymptomatic carriers. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: medRxiv, 2020 (prima pubblicazione 2020-07-24). Identificativi: DOI 10.1101/2020.07.23.20160457. Pagina: https://europepmc.org/article/PPR/PPR192031 — https://doi.org/10.1101/2020.07.23.20160457. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-08T00:21:32.745Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.